or Try an Advanced Search...

    Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 5.89 -2.48% -0.15
    RXRX closed down 3.67 percent on Wednesday, November 20, 2024, on 3.06 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical RXRX trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish -2.48%
    Volume Surge Other -2.48%
    New 52 Week Low Weakness -2.48%
    Outside Day Range Expansion -2.48%
    Lower Bollinger Band Touch Weakness -2.48%
    Oversold Stochastic Weakness -2.48%
    MACD Bearish Centerline Cross Bearish -6.06%
    Bullish Engulfing Bullish -6.06%
    New 52 Week Low Weakness -6.06%
    Outside Day Range Expansion -6.06%
    Older End-of-Day Signals for RXRX ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % 3 minutes ago
    Down 1% 3 minutes ago
    Lower Bollinger Band Support about 21 hours ago
    Outside Day about 22 hours ago
    Fell Below Lower Bollinger Band about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    RXRX Chart by TradingView
    Basic chart:

    Profile

    Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare

    Is RXRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Recursion: No News Isn't Good News When It Comes To Vanilla Pipeline
    Nov 20 Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
    Nov 15 Nvidia Discloses Stake In Applied Digital, Keeps Arm, SoundHound Stakes
    Nov 13 Recursion and Exscientia Shareholders Approve the Proposed Combination
    Nov 12 Recursion Announces the Release of OpenPhenom-S/16 in Google Cloud’s Model Garden
    Nov 10 Analysts' Revenue Estimates For Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Are Surging Higher
    Nov 6 Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates
    Nov 6 Recursion Pharmaceuticals: Q3 Earnings Snapshot
    Nov 6 Recursion Pharmaceuticals EPS of -$0.34 misses by $0.01, revenue of $26.1M misses by $3.73M
    Nov 6 Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
    See more RXRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 15.74
    52 Week Low 5.7
    Average Volume 5,548,594
    200-Day Moving Average 8.34
    50-Day Moving Average 6.65
    20-Day Moving Average 6.73
    10-Day Moving Average 6.83
    Average True Range 0.51
    RSI (14) 40.48
    ADX 17.32
    +DI 20.84
    -DI 25.42
    Chandelier Exit (Long, 3 ATRs) 6.97
    Chandelier Exit (Short, 3 ATRs) 7.22
    Upper Bollinger Bands 7.67
    Lower Bollinger Band 5.78
    Percent B (%b) 0.14
    BandWidth 28.13
    MACD Line -0.07
    MACD Signal Line 0.04
    MACD Histogram -0.1154
    Fundamentals Value
    Market Cap 1.26 Billion
    Num Shares 208 Million
    EPS -1.46
    Price-to-Earnings (P/E) Ratio -4.14
    Price-to-Sales 49.87
    Price-to-Book 4.88
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.05
    Resistance 3 (R3) 7.04 6.71 6.88
    Resistance 2 (R2) 6.71 6.45 6.71 6.82
    Resistance 1 (R1) 6.37 6.29 6.21 6.38 6.77
    Pivot Point 6.04 6.04 5.95 6.04 6.04
    Support 1 (S1) 5.70 5.78 5.54 5.71 5.31
    Support 2 (S2) 5.37 5.62 5.37 5.26
    Support 3 (S3) 5.03 5.37 5.20
    Support 4 (S4) 5.04